TLR5 and colitis: Chassaing et al. (2015) demonstrated that CMC (1% w/v) and P80 (1% v/v) each induced low-grade inflammation in wild-type mice and promoted robust colitis in IL10−/− and TLR5−/− C57Bl/6 mice after 12 weeks of administration [11].